ClinicalTrials.gov
ClinicalTrials.gov Menu

Salvage Therapy With Idarubicin in Relapsing CNS Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00210366
Recruitment Status : Terminated (due to slow accrual)
First Posted : September 21, 2005
Last Update Posted : July 30, 2010
Sponsor:
Information provided by:
International Extranodal Lymphoma Study Group (IELSG)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : July 2010
  Study Completion Date : No date given